These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16276574)

  • 1. Sources of meth. U.S. Drug Enforcement Administration (DEA).
    GMHC Treat Issues; 2005; 19(7-8):14-5. PubMed ID: 16276574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optometry and the drug enforcement administration.
    Bartlett JD; Wood JW
    J Am Optom Assoc; 1981 Jun; 52(6):495-8. PubMed ID: 7264139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Drug Enforcement Agency and DEA Form 104.
    Stratton WT
    Kans Med; 1994 Oct; 95(10):212, 214. PubMed ID: 7815771
    [No Abstract]   [Full Text] [Related]  

  • 4. The meth menace: battling the fast-paced spread of methamphetamine may mean attacking it from several fronts.
    Boulard G
    State Legis; 2005 May; 31(5):14-8. PubMed ID: 15892208
    [No Abstract]   [Full Text] [Related]  

  • 5. Guidelines for prescribers of controlled substances. A joint statement of the Drug Enforcement Administration and the DEA/Practitioners Working Committee.
    J Conn State Dent Assoc; 1981 Mar; 55(1):18-9. PubMed ID: 6785326
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug Enforcement Administration (DEA) chemists erred in calculating quantity of methadone that could be synthesized from precursor chemicals.
    Zedeck MS
    J Forensic Sci; 1997 Mar; 42(2):349-50. PubMed ID: 9068200
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescriptions; requirements clarification--Drug Enforcement Administration (DEA). Final rule.
    Fed Regist; 1991 Jun; 56(106):25025-7. PubMed ID: 10111144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clandestine drug laboratory situation in the United States.
    Frank RS
    J Forensic Sci; 1983 Jan; 28(1):18-31. PubMed ID: 6680736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placement of gamma-butyrolactone in List I of the Controlled Substances Act (21 U.S.C. 802(34)). Drug Enforcement Administration, Justice. Final rule.
    Fed Regist; 2000 Apr; 65(79):21645-7. PubMed ID: 11010670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The federal Drug Enforcement Administration "prescription series" proposal: continuing concerns.
    Gilson AM; Joranson DE
    J Pain Palliat Care Pharmacother; 2007; 21(4):21-4. PubMed ID: 18032312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meth labs.
    Goss JF
    JEMS; 1998 Jan; 23(1):50-2, 54, 56 passim. PubMed ID: 10178102
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacists correcting schedule II prescriptions: DEA flip-flops continue.
    Abood RR
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):393-6. PubMed ID: 21133749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Government's view of where we stand in drug law enforcement.
    Bartels JR
    Med Times; 1974 Sep; 102(9):47-52. PubMed ID: 4855165
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug enforcement administration liability for false arrest of physician.
    Brushwood DB
    J Pain Palliat Care Pharmacother; 2009; 23(2):156-62. PubMed ID: 19492217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Enforcement Administration and its relationship to JCAH.
    JCAH Perspect; 1986; 6(3-4):16-8. PubMed ID: 10289690
    [No Abstract]   [Full Text] [Related]  

  • 16. Dear DEA.
    Heit HA; Covington E; Good PM
    Pain Med; 2004 Sep; 5(3):303-8. PubMed ID: 15367311
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug Enforcement Administration and its relationship to JCAH.
    Mullen PE
    JCAH Perspect; 1985; 5(6):11-3. PubMed ID: 10289682
    [No Abstract]   [Full Text] [Related]  

  • 18. Implementation of the Methamphetamine Anti-Proliferation Act; thresholds for retailers and for distributors required to submit mail order reports; changes to mail order reporting requirements. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2003 Oct; 68(194):57799-804. PubMed ID: 14535265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Authorized sources of narcotic raw materials. Final rule.
    Fed Regist; 2008 Feb; 73(25):6843-51. PubMed ID: 18389916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schedules of controlled substances: rescheduling of the Food and Drug Administration approved product containing synthetic dronabinol [(-) - [DELTA] less than 9 greater than - (trans)-tetrahydrocannabinol] in sesame oil and encapsulated in soft gelatin capsules from schedule II to schedule III. Department of Justice (DOJ), Drug Enforcement Administration (DEA). Final rule.
    Fed Regist; 1999 Jul; 64(127):35928-30. PubMed ID: 10558581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.